The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by S&P BSE Low Volatility Total Return Index, subject to
tracking error.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -4.02% | -8.64% | -7.43% | -12.7% | -12.95% | -7.16% | 4.59% | 8.31% | N/A | N/A | 8.49% |
| Category returns | -3.49% | -4.55% | -2.01% | -3.44% | -4% | -2.79% | 10.35% | 12.84% | 9.89% | 11.18% | N/A |
| Absolute returns | -4.02% | -8.64% | -7.43% | -12.7% | -12.95% | -13.82% | 14.42% | 37.65% | N/A | N/A | 45.21% |
| Rank within category | 105/216 | 198/207 | 185/199 | 180/193 | 170/184 | 90/116 | 59/65 | 39/49 | N/A | N/A | N/A |
| Index Funds | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Yearly returns | N/A | 28.88% | 9.86% | 7.4% | -13.93% |
| Q1 returns | N/A | -2.49% | 7.17% | -2.78% | -12.98% |
| Q2 returns | -2.76% | 11.06% | 6.88% | 8.76% | 7.26% |
| Q3 returns | 8.15% | 4.9% | 8.01% | -3.37% | -6.84% |
| Q4 returns | 5.04% | 13.44% | -11.19% | 5.12% | -1.02% |
1% on or before 15D, Nil after 15D
| Alpha | -0.0588918 |
| Beta | 0.9318 |
| Sharpe Ratio | 0.00259803 |
| Sortino Ratio | 0.00439011 |
| R-Squared | 0.832 |
| Tracking Error | 1.5138 |
| Downside Risk | 20.5793 |
| Std. Deviation (Annualised) | 12.712 |
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential NASDAQ 100 Index Fund - Growth | -1.52% | 1.37% | 12.73% | 20.33% | 27.46% | 30.85% | 18.72% | N/A | 18.87% | 3,738.17 | 1.06 | 0.39 | Very High |
| Motilal Oswal S&P 500 Index Fund - Regular Plan - Growth | -0.5% | 1.6% | 10.19% | 15.5% | 24.15% | 26.62% | 16.54% | N/A | 19.94% | 4,584.30 | 1.04 | 0.44 | Very High |
| ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth | -4.18% | -0.29% | 13.6% | 15.38% | 14.48% | 18.13% | N/A | N/A | 18.71% | 163.10 | 1.18 | 0.29 | Very High |
| UTI Nifty 500 Value 50 Index Fund - Regular Plan - Growth | -4.93% | -6.29% | -9.73% | -4.85% | 2.97% | 18.1% | N/A | N/A | 23.08% | 838.01 | 1.21 | 0.21 | Very High |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - Growth | -4.3% | -1.59% | 11.56% | 11.09% | 13.2% | 17.83% | 12.7% | N/A | 14.93% | 191.85 | 1.10 | 0.32 | Very High |
| Motilal Oswal BSE Enhanced Value Index Fund - Regular Plan - Growth | -3.42% | -6.2% | -9.67% | -9.99% | -0.86% | 17.49% | N/A | N/A | 24.9% | 2,131.66 | 1.12 | 0.19 | Very High |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -4.83% | -1.02% | 10.76% | 12.27% | 8.48% | 15.62% | 10.2% | N/A | 15.72% | 364.19 | 1.11 | 0.18 | Very High |
| Kotak Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -5.01% | -1.19% | 10.63% | 11.86% | 8.08% | 15.42% | N/A | N/A | 24.48% | 259.53 | 0.92 | 0.18 | Very High |
| ICICI Prudential Nifty Auto Index Fund - Regular Plan - Growth | -5.75% | -5.5% | -2.85% | -7.06% | -5.92% | 15.29% | N/A | N/A | 19.15% | 234.49 | 0.95 | 0.18 | Very High |
| Motilal Oswal BSE Low Volatility Index Fund - Regular Plan - Growth Current | -4.02% | -8.64% | -7.43% | -12.7% | -12.95% | 4.59% | N/A | N/A | 8.49% | 59.15 | 1.18 | 0.00 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Castrol India Ltd. | Petroleum Products | Domestic Equities | 4.94% |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | 4.48% | |
| Marico Ltd. | Agricultural Food & other Products | Domestic Equities | 3.65% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.62% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 3.48% |
| ITC Ltd. | Diversified FMCG | Domestic Equities | 3.47% |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.45% |
| NTPC Ltd. | Power | Domestic Equities | 3.42% |
| Bharti Airtel Ltd. | Telecom - Services | Domestic Equities | 3.42% |
| SBI Life Insurance Company Ltd. | Insurance | Domestic Equities | 3.41% |
| HDFC Bank Ltd. | Banks | Domestic Equities | 3.39% |
| ICICI Bank Ltd. | Banks | Domestic Equities | 3.36% |
| Kotak Mahindra Bank Ltd. | Banks | Domestic Equities | 3.34% |
| Power Grid Corporation Of India Ltd. | Power | Domestic Equities | 3.25% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.24% |
| Tata Power Company Ltd. | Power | Domestic Equities | 3.22% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.19% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.17% |
| HDFC Life Insurance Company Ltd. | Insurance | Domestic Equities | 3.12% |
| Britannia Industries Ltd. | Food Products | Domestic Equities | 3.11% |
| Reliance Industries Ltd. | Petroleum Products | Domestic Equities | 3.11% |
| Nestle India Ltd. | Food Products | Domestic Equities | 3.09% |
| Procter & Gamble Hygiene and Health Care Ltd. | Personal Products | Domestic Equities | 3.08% |
| Shree Cement Ltd. | Cement & Cement Products | Domestic Equities | 3.06% |
| Pidilite Industries Ltd. | Chemicals & Petrochemicals | Domestic Equities | 3.05% |
| Hindustan Unilever Ltd. | Diversified FMCG | Domestic Equities | 3.05% |
| Coal India Ltd. | Consumable Fuels | Domestic Equities | 2.95% |
| ACC Ltd. | Cement & Cement Products | Domestic Equities | 2.88% |
| Grasim Industries Ltd. | Cement & Cement Products | Domestic Equities | 2.88% |
| United Breweries Ltd. | Beverages | Domestic Equities | 2.85% |
| Triparty Repo | Cash & Cash Equivalents and Net Assets | 0.24% | |
| Total | 100.00% | ||
Mr. Swapnil Mayekar has more than 10 years of overall experience in the financial services industry. He has been part of fund management & product development team for Motilal Oswal Asset Management Company Ltd. Mr. Mayekar's key area of expertise is trading in equity and debt segment, quantitative analysis, creating customized indices, model testing and building research database. His last assignment was with Business Standard Limited as a Research Associate. He has done his post-graduation in Commerce (Finance Management) from University of Mumbai.
Mr. Rakesh Shetty has more than 13 years of overall experience and expertise in trading in equity, debt segment, Exchange Trade Fund’s management, Corporate Treasury and Banking. Prior to joining Motilal Oswal Asset Management Company Limited, he has worked with Company engaged in Capital Market Business wherein he was in charge of equity and debt ETFs, customized indices and has also been part of product development.
Mr. Dishant Mehta has more than 9 years of experience and expertise in Financial markets across different segment- Equities, Derivatives, Commodities and Currencies. Managed Institutional and Foreign Portfolio Investment clients.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
